Wotton Paul K
Insider CIK 1300997 · AIS President and CEO, Director · ACTC President and CEO, Director · VCEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VCEL Vericel Corp | S Sale | 2026-05-11 | 2026-05-13 | 2,500 | $33.05 | $82.6K | 26,302 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-05-11 | 2026-05-13 | 7,500 | $32.64 | $244.8K | 18,802 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2026-04-29 | 2026-05-01 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 28,802 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-12-03 | 2025-12-04 | 2,500 | $37.83 | $94.6K | 25,602 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-12-02 | 2025-12-04 | 2,500 | $37.97 | $94.9K | 28,102 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2025-04-30 | 2025-05-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 30,602 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-12-04 | 2024-12-05 | 2,600 | $58.72 | $152.7K | 27,402 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 30,002 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2023-12-14 | 2023-12-15 | 5,000 | $37.31 | $186.6K | 26,802 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 31,802 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 29,202 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-05-14 | 2021-05-17 | 5,000 | $50.52 | $252.6K | 26,602 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-05-12 | 2021-05-13 | 2,200 | $48.88 | $107.5K | 31,602 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-05-11 | 2021-05-13 | 17,500 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-05-11 | 2021-05-13 | 13,125 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-05-11 | 2021-05-13 | 13,125 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-05-11 | 2021-05-13 | 13,448 | $50.11 | $673.9K | 33,802 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-05-11 | 2021-05-13 | 13,125 | $16.62 | $218.1K | 47,250 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-05-11 | 2021-05-13 | 13,125 | $14.56 | $191.1K | 34,125 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-05-11 | 2021-05-13 | 17,500 | $13.05 | $228.4K | 21,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 3,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2020-04-29 | 2020-05-01 | 1,750 | $14.56 | $25.5K | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2019-01-02 | 2019-01-04 | 17,500 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2019-01-02 | 2019-01-04 | 5,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2019-01-02 | 2019-01-04 | 5,000 | $2.76 | $13.8K | 5,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2019-01-02 | 2019-01-04 | 5,000 | $16.83 | $84.1K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2019-01-02 | 2019-01-04 | 17,500 | $2.63 | $46.0K | 17,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2019-01-02 | 2019-01-04 | 17,500 | $16.83 | $294.5K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2018-06-18 | 2018-06-20 | 5,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2018-06-18 | 2018-06-20 | 15,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2018-06-18 | 2018-06-20 | 10,000 | — | $0 | 5,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2018-06-18 | 2018-06-20 | 10,000 | $2.76 | $27.6K | 15,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2018-06-18 | 2018-06-20 | 5,000 | $3.74 | $18.7K | 5,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2018-06-18 | 2018-06-20 | 15,000 | $3.74 | $56.1K | 30,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2018-06-18 | 2018-06-20 | 10,000 | $12.06 | $120.6K | 20,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2018-06-18 | 2018-06-20 | 15,000 | $12.06 | $180.9K | 5,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2018-06-18 | 2018-06-20 | 5,000 | $12.06 | $60.3K | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2018-05-02 | 2018-05-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2017-05-03 | 2017-05-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2016-05-04 | 2016-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 300,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | U Tender | 2016-02-10 | 2016-02-11 | 277,500 | $8.50 | $2.36M | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | F Tax w/h | 2015-07-30 | 2015-07-31 | 32,500 | $4.23 | $137.5K | 267,500 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2015-03-20 | 2015-03-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-03-05 | 2015-03-09 | 10,000 | — | $0 | 310,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-07-30 | 2014-07-31 | 30,000,000 | — | $0 | 30,000,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-07-30 | 2014-07-31 | 30,000,000 | — | $0 | 30,000,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 154,825 | — | $0 | 1,572,308 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 177,994 | — | $0 | 848,728 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 88,997 | — | $0 | 937,725 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2014-02-20 | 2014-02-24 | 3,309 | $4.85 | $16.0K | 670,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-02-20 | 2014-02-24 | 10,309 | — | $0 | 674,043 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2014-02-11 | 2014-02-13 | 11,000 | $4.45 | $49.0K | 663,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2014-02-11 | 2014-02-13 | 34,000 | — | $0 | 674,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-15 | 2014-01-17 | 22,900 | — | $0 | 1,417,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-15 | 2014-01-17 | 22,900 | $0.50 | $11.4K | 731,634 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2014-01-15 | 2014-01-17 | 22,900 | $5.10 | $116.8K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-12-09 | 2013-12-10 | 18,100 | — | $0 | 1,440,383 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-12-09 | 2013-12-10 | 18,100 | $0.50 | $9.1K | 726,834 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-12-09 | 2013-12-10 | 18,100 | $4.00 | $72.4K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-12-06 | 2013-12-10 | 46,000 | — | $0 | 1,458,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-12-06 | 2013-12-10 | 46,000 | $4.00 | $184.0K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-12-06 | 2013-12-10 | 46,000 | $0.50 | $23.0K | 754,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-10-01 | 2013-10-03 | 35,000 | — | $0 | 1,504,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-10-01 | 2013-10-03 | 35,000 | $0.50 | $17.5K | 743,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-10-01 | 2013-10-03 | 35,000 | $4.19 | $146.7K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-09-03 | 2013-09-05 | 35,000 | — | $0 | 1,539,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-09-03 | 2013-09-05 | 35,000 | $0.50 | $17.5K | 743,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-09-03 | 2013-09-05 | 35,000 | $4.41 | $154.3K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-08-01 | 2013-08-05 | 35,000 | — | $0 | 1,574,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-08-01 | 2013-08-05 | 35,000 | $4.42 | $154.7K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-08-01 | 2013-08-05 | 35,000 | $0.50 | $17.5K | 743,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-07-01 | 2013-07-03 | 35,000 | — | $0 | 1,609,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-07-01 | 2013-07-03 | 35,000 | $0.50 | $17.5K | 743,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-07-01 | 2013-07-03 | 35,000 | $4.14 | $144.9K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-06-03 | 2013-06-05 | 125,000 | — | $0 | 1,644,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-03 | 2013-06-05 | 125,000 | $4.01 | $501.3K | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-06-03 | 2013-06-05 | 125,000 | $0.50 | $62.5K | 833,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2013-05-22 | 2013-05-24 | 163,690 | — | $0 | 1,769,483 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 92,593 | — | $0 | 616,141 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 92,593 | — | $0 | 708,734 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-05-06 | 2013-05-08 | 10,000 | — | $0 | 1,605,793 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-05-06 | 2013-05-08 | 10,000 | $4.04 | $40.4K | 523,547 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-05-06 | 2013-05-08 | 10,000 | $0.50 | $5.0K | 533,547 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-01-08 | 2013-01-10 | 25,000 | — | $0 | 1,615,793 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-01-08 | 2013-01-10 | 25,000 | $4.01 | $100.3K | 537,393 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-01-08 | 2013-01-10 | 25,000 | $0.50 | $12.5K | 562,393 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-12-04 | 2012-12-06 | 25,000 | — | $0 | 1,640,793 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-12-04 | 2012-12-06 | 25,000 | $0.50 | $12.5K | 562,393 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2012-12-04 | 2012-12-06 | 25,000 | $4.00 | $100.0K | 537,393 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2012-07-06 | 2012-07-10 | 110,293 | — | $0 | 1,665,793 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2012-07-06 | 2012-07-10 | 54,773 | — | $0 | 537,393 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award deriv | 2012-05-17 | 2012-05-21 | 150,000 | — | $0 | 1,555,500 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-02-10 | 2012-02-13 | 6,948 | — | $0 | 482,620 | SEC↗ |